Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
PUT
Coherent
COHR
$53.9B
| $47.7M | 0.01% |
735,000
+416,800
| +131% | +$34.5M |
|
1052
Analog Devices
ADI
$181B
| $47.7M | 0.01% |
236,320
-19,870
| -8% | -$4.29M |
|
1053
CALL
CF Industries
CF
$19.6B
| $47.5M | 0.01% |
608,300
+211,300
| +53% | +$17.7M |
|
1054
CALL
Albertsons Companies
ACI
$6.12B
| $47.5M | 0.01% |
2,161,800
-1,401,700
| -39% | -$28.9M |
|
1055
PUT
Sempra
SRE
$55.3B
| $47.5M | 0.01% |
665,100
+621,200
| +1,415% | +$48.4M |
|
1056
PUT
Trip.com Group
TCOM
$29B
| $47.4M | 0.01% |
746,000
+325,600
| +77% | +$21.3M |
|
1057
CALL
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.6B
| $47.3M | 0.01% |
657,300
-42,800
| -6% | -$3.48M |
|
1058
PUT
TotalEnergies
TTE
$198B
| $47.3M | 0.01% |
731,100
+177,900
| +32% | +$10.7M |
|
1059
Madrigal Pharmaceuticals
MDGL
$11.8B
| $47.2M | 0.01% |
142,643
+126,320
| +774% | +$41.5M |
|
1060
CALL
Tenet Healthcare
THC
$22.4B
| $47.2M | 0.01% |
350,800
-34,600
| -9% | -$4.56M |
|
1061
PUT
Cal-Maine
CALM
$3.95B
| $47M | 0.01% |
516,700
+390,300
| +309% | +$38.5M |
|
1062
PUT
EOG Resources
EOG
$78.8B
| $46.8M | 0.01% |
364,800
-12,200
| -3% | -$1.57M |
|
1063
CALL
DexCom
DXCM
$34.4B
| $46.7M | 0.01% |
684,500
-547,300
| -44% | -$44.7M |
|
1064
Zillow
ZG
$8.53B
| $46.7M | 0.01% |
698,564
-340,438
| -33% | -$25.2M |
|
1065
PUT
HSBC
HSBC
$357B
| $46.6M | 0.01% |
812,200
+560,800
| +223% | +$30.7M |
|
1066
PUT
Toyota
TM
$229B
| $46.6M | 0.01% |
264,000
+66,700
| +34% | +$12.4M |
|
1067
RB Global
RBA
$15.6B
| $46.5M | 0.01% |
463,563
+228,787
| +97% | +$21.8M |
|
1068
CALL
Southern Copper
SCCO
$181B
| $46.3M | 0.01% |
525,673
+197,199
| +60% | +$17.5M |
|
1069
PUT
Corcept Therapeutics
CORT
$13.3B
| $46.3M | 0.01% |
405,200
+304,500
| +302% | +$18.5M |
|
1070
VanEck Gold Miners ETF
GDX
$32.2B
| $46.2M | 0.01% |
1,005,763
-1,689,964
| -63% | -$68.3M |
|
1071
Bank of America
BAC
$436B
| $46.1M | 0.01% |
1,103,925
-2,605,926
| -70% | -$116M |
|
1072
CALL
DuPont de Nemours
DD
$18.5B
| $45.9M | 0.01% |
489,870
-300,503
| -38% | -$29.3M |
|
1073
Energy Transfer Partners
ET
$72.6B
| $45.9M | 0.01% |
2,467,681
+2,250,029
| +1,034% | +$43.8M |
|
1074
CALL
Cinemark Holdings
CNK
$4.45B
| $45.9M | 0.01% |
1,842,700
+1,506,500
| +448% | +$41.9M |
|
1075
CALL
TransDigm Group
TDG
$66.3B
| $45.6M | 0.01% |
33,000
-16,700
| -34% | -$22.3M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,483 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.